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Surgical innovation strives to address the perceived 
shortcomings and potential pitfalls associated with 
traditional therapeutic techniques. New devices are often 
recommended to patients on the basis of incomplete 
clinical datasets that highlight speciﬁ c short-term gains 
over standard treatment but may not conﬁ rm long-
term beneﬁ t. Enthusiasm for new technology in surgery 
should be balanced by the requirement to undertake 
objective, high-quality studies to establish the overall 
clinical and economic eﬀ ect of surgical therapies.1
In The Lancet, Angus Watson and colleagues present 
eTHoS,2 a randomised, non-blinded, multicentre, phase 3 
study assessing clinical outcomes and cost-eﬀ ectiveness 
for treatment of moderate or severe haemorrhoids 
using novel stapled haemorrhoidopexy versus the long-
established traditional excisional haemorrhoidectomy.2 
These outcomes are of importance as each year millions 
of people are aﬀ ected by haemorrhoids worldwide;3 
the UK National Health Service carries out in excess of 
20 000 haemorrhoidal treatments.4
Traditional haemorrhoidectomy excises symptomatic 
tissue from the anal canal leaving wounds that usually 
take 6 weeks to heal.5 Surgeons often contend that 
traditional haemorrhoidectomy is a good treatment for 
haemorrhoids, the axiom of “6 weeks’ pain for 5 years’ 
gain” has long been touted, although surprisingly little 
high-quality evidence exists to support this position.6 
Patients experience short-term discomfort after traditional 
haemorrhoidectomy until their anal canal wounds heal, 
and, if severe, this pain might give rise to additional 
problems such as a fear of evacuation, constipation, and 
an inability to pass urine requiring catheterisation.
Stapled haemorrhoidopexy was speciﬁ cally developed 
to tackle the problem of early pain after traditional 
haemorrhoidectomy.7 A ring of tissue is excised from the 
relatively insensate, viscerally innervated upper anal canal, 
with the cut edges simultaneously brought together and 
ﬁ xed by a circle of staples. Traction draws the prolapsing 
haemorrhoids into the anal canal where they remain ﬁ xed 
(pexy). Stapling might also interrupt the submucosal 
blood ﬂ ow to haemorrhoids, thereby reducing symptoms 
of bleeding. Initial experience reinforced the view that 
stapled haemorrhoidopexy was less painful for patients 
than traditional haemorrhoidectomy, however, severe 
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selection, patients’ treatment choices, and continuous 
surveillance after EVAR. These results also show that 
long-term follow-up of surgical innovations is crucial.12
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unexpected complications were also reported, most 
notably chronic anal pain and rectovaginal ﬁ stula.8,9 A 
large number of procedures have been done worldwide, 
and 14 000 cases have been published,10 but the eﬃ  cacy 
of stapled haemorrhoidectomy in relation to traditional 
haemorrhoidectomy remains unknown.11 
Between 2011 and 2014, eTHoS randomised 
777 patients with symptomatic grade 2–4 haemorrhoids 
to stapled haemorrhoidopexy (n=389) or traditional 
haemorrhoidectomy (n=388) at 32 UK sites.2 Patients 
who had previously not responded well to treatment 
with rubber band ligation or haemorrhoidal artery 
ligation were eligible, in addition to cases where such 
techniques were deemed unsuitable on account of large 
size. Previous traditional haemorrhoidectomy or stapled 
haemorrhoidopexy constituted exclusions. The primary 
outcome comprised serial assessment of quality of life 
with the use of EuroQol 5 dimensions (EQ-5D) over a 
2-year period, expressed as the area under the curve 
(AUC), so capturing both early and late eﬀ ects of surgery.
The investigators showed that EQ-5D AUC (24 months) 
was signiﬁ cantly higher (better) in the traditional 
haemorrhoidectomy group than in the novel stapled 
haemorrhoidopexy (mean diﬀ erence –0·073 [95% CI 
–0·140 to –0·006]; p=0·0342). Stapled haemorrhoidopexy 
was much more expensive than traditional haem-
orrhoidectomy, with respective mean costs of £941 
(SD 415) per patient versus £602 (507) for traditional 
excisional haemorrhoidectomy, leading to higher cost per 
quality-adjusted life-year for stapled haemorrhoidopexy. 
Notably, use of expensive modern energy devices for 
traditional haemorrhoidectomy12 was precluded in eTHoS.
In the immediate postoperative period, stapled 
haemorrhoidopexy provided superior quality of life 
compared with traditional haemorrhoidectomy for up 
to 6 weeks. Participants reported better pain scores 
for stapled haemorrhoidopexy at 1 and 3 weeks, but 
by 6 weeks, any beneﬁ t was lost. This early beneﬁ t 
for stapled haemorrhoidopexy was subsequently 
overshadowed by consistent medium-term and longer 
term gains for traditional haemorrhoidectomy. At 12 and 
24 months EQ-5D unequivocally favoured traditional 
haemorrhoidectomy. Traditional haemorrhoidectomy 
consistently improved (reduced) Cleveland incontinence 
scores and haemorrhoid symptom scores by a small 
but signiﬁ cant margin. The proportion of patients 
who reported that their haemorrhoids had recurred 
at 12 months was only 14% (39/278) for traditional 
haemorrhoidectomy compared with 32% (94/295) for 
stapled haemorrhoidopexy.
Complication rates were reassuringly similar and low 
for both procedures, a testimony to the high quality 
of surgery delivered throughout the trial. No episodes 
of rectal perforation occurred. At 12 months, the 
debilitating symptom of tenesmus regularly aﬀ ected 
(ie, always or often) 13% (38/295) of patients who had 
stapled haemorrhoidopexy compared with 4% (11/278) 
who had traditional haemorrhoidectomy.
These ﬁ ndings add to those of the HubBLe study.13 
Together HubBLe and eTHoS have set a benchmark 
for assessment of technological innovation across the 
spectrum of haemorrhoidal disease. In both studies, the 
novel pexy approach has proven inferior to conventional 
treatment. For mild to moderate haemorrhoids, 
haemorrhoidal artery ligation was no better than a 
course of banding but incurred much more cost.13 For 
moderate to severe haemorrhoids, although stapled 
haemorrhoidopexy produced less short-term pain than 
traditional haemorrhoidectomy, longer term outcomes 
were worse and costs much more.2 Since 2007, the 
National Institute for Health and Care Excellence (NICE) 
has recommended use of stapled haemorrhoidopexy for 
patients with prolapsed haemorrhoids; the only qualiﬁ er 
being that surgery was considered a suitable treatment.14 
In retrospect, this approval was premature as even 
then, available evidence pointed to higher failure and 
reintervention rates for stapled haemorrhoidopexy than 
for traditional haemorrhoidectomy. Cost-eﬀ ectiveness 
was also questioned at the time. Although innovation is 
to be encouraged, unproven devices should be assessed in 
the context of suitable prospective clinical studies as NICE 
belatedly acknowledged in dealing with use of colonic 
stents for obstructing bowel cancer.15 Finally, and long 
overdue, these studies provide high-quality information 
for patients with haemorrhoids on what to expect after 
standard surgical treatment; 5 weeks’ pain with a high 
probability of at least 2 years gain. The search continues for 
an eﬀ ective painless approach to haemorrhoid treatment.
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In their Article1 in The Lancet, Héctor Gómez-Dantés and 
colleagues make the case for a non-typical, dissonant 
health transition in Mexico. The authors describe how 
Mexico shifted from a standard transition observed 
before 2000 to a non-typical health transition, in 
which health outcomes for some groups (male adults) 
presented almost no improvements overall, mostly due 
to interpersonal violence and chronic kidney disease.
Building on the methods developed for the Global 
Burden of Disease study (GBD 2013),2 the authors present 
a subnational analysis of Mexico’s health, reporting 
heterogeneity across states in terms of years of life 
lost and life expectancy, highlighting important issues 
related to health inequalities. The reported diﬀ erences 
represent a diﬀ erential burden that is related to the 
places people live in, that is, to their living conditions.1
The social determinants of health have been well 
described previously.3,4 Interpersonal violence in Mexico 
has increased in a pattern related to drug traﬃ  c and 
other criminal actions by organised delinquency; some 
individuals are at higher risk of dying from violence 
than individuals in other areas because of where they 
live, a factor also related to income inequality, with high 
homicide rates in places with high income inequality.5 
Similarly, the probability of dying from a chronic condition, 
such as chronic kidney disease, is related to the quality of 
health care an individual can access, which is closely related 
to their socioeconomic background and where they live.
A global discussion on inequalities is ongoing and 
the relevance of addressing them is clearly stated in 
the Sustainable Development Goals, which include 
reduction of inequality as one of the 17 global objectives.6 
Health inequalities: Mexico’s greatest challenge
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